Natera, Inc. (NTRA) Financial Statements (2026 and earlier)

Company Profile

Business Address 13011 MCCALLEN PASS
AUSTIN, TX 78753
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 8071 - Medical Laboratories (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2026
MRQ
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments  22,689236,882898,306914,282737,274
Cash and cash equivalent    466,00584,38648,668
Short-term investments  22,689236,882432,301829,896688,606
Restricted cash and investments    86228187
Receivables296,528314,165278,289244,385122,07478,565
Inventory, net of allowances, customer advances and progress billings68,44344,74440,75935,40626,90920,031
Inventory68,44344,74440,75935,40626,90920,031
Other undisclosed current assets1,131,968994,222702,61933,63429,64526,606
Total current assets:1,496,9391,375,8201,258,5491,211,8171,093,138862,663
Noncurrent Assets
Operating lease, right-of-use asset108,54186,14956,53771,87459,01321,399
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization241,184162,046111,21092,45365,51633,348
Intangible asset, including goodwill, after accumulated amortization514,783     
Goodwill141,070     
Intangible asset, excluding goodwill, after accumulated amortization373,713     
Other noncurrent assets36,89736,72015,40318,33018,82014,743
Total noncurrent assets:901,405284,915183,150182,657143,34969,490
TOTAL ASSETS:2,398,3441,660,7351,441,6991,394,4741,236,487932,153
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities125,75997,03660,85575,15868,14798,874
Employee-related liabilities✕✕✕✕44,01040,94130,371
Accounts payable33,15634,92214,99831,14827,2068,096
Accrued liabilities92,60362,11445,857  60,407
Deferred revenue24,90719,75416,61210,7777,40450,125
Debt80,32380,36280,40280,35050,05250,054
Business combination, contingent consideration, liability21,580     
Other liabilities188,659146,893149,405144,21493,353 
Total current liabilities:441,228344,045307,274310,499218,956199,053
Noncurrent Liabilities
Long-term debt and lease obligation   282,945281,653341,430223,739
Long-term debt, excluding current maturities   282,945281,653280,394202,493
Liabilities, other than long-term debt244,002113,42686,15396,57822,79723,125
Deferred revenue17,06216,83819,12820,00121,31822,805
Other liabilities11,687   1,479320
Operating lease, liability118,47396,58867,02576,57761,03621,246
Business combination, contingent consideration, liability96,780     
Other undisclosed noncurrent liabilities7017,844    
Total noncurrent liabilities:244,703121,270369,098378,231364,227246,864
Total liabilities:685,931465,315676,372688,730583,183445,917
Equity
Equity, attributable to parent1,712,4131,195,420765,327705,744653,304486,236
Common stock14121111109
Additional paid in capital4,488,6793,763,6143,145,8372,664,7302,050,4171,411,286
Accumulated other comprehensive income (loss)(258)(344)(3,085)(16,362)(2,287)4,259
Accumulated deficit(2,776,022)(2,567,862)(2,377,436)(1,942,635)(1,394,836)(929,318)
Total equity:1,712,4131,195,420765,327705,744653,304486,236
TOTAL LIABILITIES AND EQUITY:2,398,3441,660,7351,441,6991,394,4741,236,487932,153

Income Statement (P&L) ($ in thousands)

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenues2,306,1131,696,9111,082,571820,222625,486391,005
Cost of revenue(809,146)(672,474)(587,186)(412,586)(276,274)(202,266)
Gross profit:1,496,9671,024,437495,385407,636349,212188,739
Operating expenses(1,806,878)(1,246,731)(941,630)(948,676)(817,386)(405,016)
Operating loss:(309,911)(222,294)(446,245)(541,040)(468,174)(216,277)
Nonoperating income
(Other Nonoperating income)
      
Interest and debt expense (10,685)(12,638)(9,319)(8,305)(20,930)
Loss from continuing operations before equity method investments, income taxes:(309,911)(232,979)(458,883)(550,359)(476,479)(237,207)
Other undisclosed income from continuing operations before income taxes41,82243,24824,3533,5385,3817,562
Loss from continuing operations before income taxes:(268,089)(189,731)(434,530)(546,821)(471,098)(229,645)
Income tax expense (benefit)59,929(695)(271)(978)(618)(98)
Loss from continuing operations:(208,160)(190,426)(434,801)(547,799)(471,716)(229,743)
Loss before gain (loss) on sale of properties:✕✕✕✕✕(471,716)(229,743)
Net loss available to common stockholders, diluted:(208,160)(190,426)(434,801)(547,799)(471,716)(229,743)

Comprehensive Income ($ in thousands)

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Net loss:(208,160)(190,426)(434,801)(547,799)(471,716)(229,743)
Comprehensive loss:(208,160)(190,426)(434,801)(547,799)(471,716)(229,743)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent862,74113,277(14,075)(6,546)3,340
Comprehensive loss, net of tax, attributable to parent:(208,074)(187,685)(421,524)(561,874)(478,262)(226,403)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: